GEN Pharmaceuticals Secures Approval to Test New Parkinson's Treatment in Europe

Amsterdam, Monday, 16 March 2026.
Securing Dutch ethical approval, GEN Pharmaceuticals will launch a Phase II trial this April for a novel drug uniquely targeting cellular energy loss to combat Parkinson’s disease.